Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

How much are we spending? The estimation of research expenditures on cardiovascular disease in Canada.

de Oliveira C, Nguyen VH, Wijeysundera HC, Wong WW, Woo G, Liu PP, Krahn MD.

BMC Health Serv Res. 2012 Aug 28;12:281. doi: 10.1186/1472-6963-12-281.

3.

Evaluation of funding gastroenterology research in Canada illustrates the beneficial role of partnerships.

Sherman PM, Banks Hart K, Rose KL, Bosompra K, Manuel C, Belanger P, Daniels S, Sinclair P, Vanner S, Buret A.

Can J Gastroenterol. 2013 Dec;27(12):717-20.

4.

Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.

Kelly R, Zoubiane G, Walsh D, Ward R, Goossens H.

Lancet Infect Dis. 2016 Apr;16(4):431-40. doi: 10.1016/S1473-3099(15)00350-3. Epub 2015 Dec 19.

5.

Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom.

Sussex J, Feng Y, Mestre-Ferrandiz J, Pistollato M, Hafner M, Burridge P, Grant J.

BMC Med. 2016 Feb 24;14:32. doi: 10.1186/s12916-016-0564-z.

6.

Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes.

Glover M, Buxton M, Guthrie S, Hanney S, Pollitt A, Grant J.

BMC Med. 2014 Jun 16;12:99. doi: 10.1186/1741-7015-12-99.

7.

The returns from cardiovascular research: the impact of the National Heart Foundation of Australia's investment.

Clay MA, Donovan C, Butler L, Oldenburg BF.

Med J Aust. 2006 Aug 21;185(4):209-12.

PMID:
16922666
9.

The anatomy of medical research: US and international comparisons.

Moses H 3rd, Matheson DH, Cairns-Smith S, George BP, Palisch C, Dorsey ER.

JAMA. 2015 Jan 13;313(2):174-89. doi: 10.1001/jama.2014.15939.

PMID:
25585329
10.

Public funding for contraceptive, sterilization and abortion services, 1994.

Sollom T, Gold RB, Saul R.

Fam Plann Perspect. 1996 Jul-Aug;28(4):166-73.

11.

Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis.

de Oliveira C, Nguyen HV, Wijeysundera HC, Wong WW, Woo G, Grootendorst P, Liu PP, Krahn MD.

CMAJ Open. 2013 Jul 25;1(2):E83-90. doi: 10.9778/cmajo.20130003. eCollection 2013 May.

12.

A review of research related to blood transfusion in Canada, 2000-2002.

Teitel JM, Robillard P, Rock GA, Wong-Rieger D, Lai ES, Chan P.

Transfus Med. 2004 Jun;14(3):195-203. Review.

PMID:
15180811
13.
14.

A comparison of critical care research funding and the financial burden of critical illness in the United States.

Coopersmith CM, Wunsch H, Fink MP, Linde-Zwirble WT, Olsen KM, Sommers MS, Anand KJ, Tchorz KM, Angus DC, Deutschman CS.

Crit Care Med. 2012 Apr;40(4):1072-9. doi: 10.1097/CCM.0b013e31823c8d03.

PMID:
22202712
15.

Does targeted, disease-specific public research funding influence pharmaceutical innovation?

Blume-Kohout ME.

J Policy Anal Manage. 2012;31(3):641-60.

PMID:
22764378
16.

Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.

Ridker PM, Torres J.

JAMA. 2006 May 17;295(19):2270-4. Erratum in: JAMA. 2006 Jun 21;295(23):2726.

PMID:
16705108
17.

Birth of the Canadian Digestive Health Foundation.

Beck IT.

Can J Gastroenterol. 2004 Jan;18(1):29-37.

PMID:
14760429
18.

A source of innovation.

Gillespie DG.

Integration. 1992 Dec;(34):2-7.

PMID:
12317827
19.

Role of government in cardiovascular research.

Friesen HG.

Can J Cardiol. 1994 Oct;10(8):811-4.

PMID:
7954015
20.

Little science, big science: strategies for research portfolio selection in academic surgery departments.

Shah A, Pietrobon R, Cook C, Sheth NP, Nguyen L, Guo L, Jacobs DO, Kuo PC.

Ann Surg. 2007 Dec;246(6):1110-5.

PMID:
18043118

Supplemental Content

Support Center